Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases

BACKGROUND: Rituximab has been used successfully in the recent years for treatment of neuromyelitis optica spectrum disorders (NMOSD). However, a uniform treatment protocol for maintenance therapy and the best interval for evaluation and retreatment have not been postulated. We evaluated the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed Ahadi, Maral, Naser Moghadasi, Abdorreza, Asgari, Nasrin, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265520/
https://www.ncbi.nlm.nih.gov/pubmed/32509243
http://dx.doi.org/10.22088/cjim.11.2.155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265520/
https://www.ncbi.nlm.nih.gov/pubmed/32509243
http://dx.doi.org/10.22088/cjim.11.2.155

Ejemplares similares